Skip to main content
. 2019 Sep 27;14(3):173–177. doi: 10.5114/pg.2019.88165

Table III.

Pharmacotherapy recommended to patients with NAFLD

Pharmacotherapy recommended to patients with NAFLD N %
Statins 614 46.4
Essential phospholipids (EPL) 645 48.8
Ursodeoxycholic acid (UDCA) 633 47.9
Vitamin E 342 25.9
ω-3 fatty acids 222 16.8
Thiazolidinediones 50 3.8
Others, e.g. milk thistle extract, L-ornithine L-aspartate, thiazolidine carboxylic acid 655 49.5
I do not recommend any drugs 121 9.2